Malignant Respiratory System Neoplasm — Trials

Malignant Respiratory System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

11,125 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,648
Recruiting: 1,431
Ph III recruiting: 179
Growth YoY: +7.9%
Industry share: 37%
Top sponsor: AstraZeneca
Termination share: 34.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,490)

clinicaltrialsPublishedShowing 451–451 of 451 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00064636	Phase I Dose Escalation Study of VELCADE Plus Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors	terminated	Phase 1	46	Millennium Pharmaceuticals, Inc.INDUSTRY	0	Jun 24, 2005	clinicaltrials